Loading company…
Riskpilot
← Back to search
Sign in
Get full access
C2 BIOENGINEERING ApS
APS
Dissolved
CVR 28865686
Hovedgaden 12
Forskning og eksperimentel udvikling indenfor bioteknologi · NACE 721100
Est. 2005
1 employees
Watchlist
Share
Download PDF
Full Risika report
Overview
Financials
People & ownership
Related companies
Revenue 2017
DKK 26K
+6% vs 2016
EBITDA margin
-48.0%
+88% vs 2016
Equity ratio
95.5%
Financial strength
Net profit 2017
DKK -12K
+88% vs 2016
EBITDA — year on year
DKK millions
0M
0M
1M
1M
1M
0M
2012
0M
0%
2013
0M
0%
2014
0M
0%
2015
0M
0%
2016
0M
0%
2017
Key figures
Annual report 2017
Revenue
DKK 26K
+6%
EBITDA
DKK -12K
+88%
Net profit
DKK -12K
+88%
Total assets
DKK 204K
-5%
Equity
DKK 195K
-6%
Employees
—
—
Company information
Legal name
C2 BIOENGINEERING ApS
CVR number
28865686
Legal form
Anpartsselskab
NACE code
721100 · Forskning og eksperimentel udvikling indenfor bioteknologi
Founded
17. juni 2005
Share capital
DKK 125.000
Employees
1
VAT registered
No
Audit selected
No
Last report
2017-12-31
Financial year
January – December
Signatory rights
Selskabet tegnes af direktøren og bestyrelsesformanden.
Contact
Address
Hovedgaden 12
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
Visit risika.com
Explore
Companies in Forskning og eksperimentel udvikling indenfor bioteknologi
Companies in Greve
All Denmark companies
Revenue
DKK millions
0M
0M
1M
1M
1M
0M
2012
0M
2013
0M
2014
0M
2015
0M
2016
0M
2017
EBITDA
DKK millions
0M
0M
1M
1M
1M
0M
2012
0M
2013
0M
2014
0M
2015
0M
2016
0M
2017
Income statement
DKK thousands
Item
2012
2013
2014
2015
2016
2017
Revenue
339
63
24
190
24
26
Staff expenses
-272
-42
-66
-49
-91
-5
EBITDA
14
-19
-80
87
-106
-12
Depreciation & amort.
-0
-0
-0
-0
-0
-0
EBIT
14
-19
-80
87
-106
-12
Net financials
1
1
1
0
-0
-0
Profit before tax
15
-17
-80
87
-107
-12
Tax
-0
-0
-0
-0
-0
-0
Net profit
15
-17
-80
87
-107
-12
Balance sheet
DKK thousands
Item
2012
2013
2014
2015
2016
2017
Total assets
400
320
254
343
214
204
Equity
323
306
226
313
207
195
Long-term debt
0
0
0
0
0
0
Short-term debt
77
14
27
29
7
9
Total debt
77
14
27
29
7
9
Financial ratios
5-year trend
EBITDA margin
-48.0%
This company
15.8%
Market median
-404% vs market
2012
2017
Equity ratio
95.5%
This company
38.2%
Market median
+150% vs market
2012
2017
Return on equity
-6.3%
This company
18.4%
Market median
-134% vs market
2012
2017
Net profit margin
-48.1%
This company
8.1%
Market median
-694% vs market
2012
2017
Asset turnover
0.13×
This company
1.12×
Market median
-88% vs market
2012
2017
Debt / equity
0.05×
This company
0.62×
Market median
+92% vs market
2012
2017
Annual reports & filings
Annual report 2017
Filed via CVR / Virk · Period 2017-01-01 – 2017-12-31
View
PDF
Annual report 2016
Filed via CVR / Virk · Period 2016-01-01 – 2016-12-31
View
PDF
Annual report 2015
Filed via CVR / Virk · Period 2015-01-01 – 2015-12-31
View
PDF
Annual report 2014
Filed via CVR / Virk · Period 2014-01-01 – 2014-12-31
View
PDF
Annual report 2013
Filed via CVR / Virk · Period 2013-01-01 – 2013-12-31
View
PDF
Annual report 2012
Filed via CVR / Virk · Period 2012-01-01 – 2012-12-31
View
PDF
Management
Actively employed in the business
No data on file.
Board of directors
Non-executive oversight
No data on file.
Shareholders
As of last annual report
Shareholder
Type
Ownership
Votes
Since
Christian Lorentz Bagger
Individual
50.0%
50.0%
2005
Jens Christian Sørensen
Individual
50.0%
50.0%
2005
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive.
Learn more
.
Company hierarchy
No registered parent or subsidiaries
Board network connections
Board members of C2 BIOENGINEERING ApS also hold positions in
0
other companies.
Person
Role here
Other companies